Highlights
ASX: CP1       CANNPAL ANIMAL THERAPEUTICS LIMITED
Last Price Today's Change   Day's Range   Trading Volume
0.155   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):29,377
4 Weeks Range:0.15 - 0.18
4 Weeks Price Volatility (%):
86.11%
52 Weeks Range:0.105 - 0.195
52 Weeks Price Volatility (%):
79.49%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

CannPal Animal Therapeutics Limited is an Australia-based pet pharmaceutical company. The Company is focused on research, developing and commercializing therapeutics for the companion animal health industry, using the compounds derived from the cannabis plants. It is focused on cats and dogs. Its lead drug candidate is CPAT-01, which targets osteosarcoma pain in dogs. It is also engaged in investigating and researching the ability to use cannabidiol derived from the hemp plant for developing a nutraceutical range of products for use in companion animals, including dogs, cats, birds, horses and other domestic animals, without a prescription. It is also developing pharmaceutical therapeutics for chronic pain and appetite stimulation. It is developing nutraceutical products for skin conditions, joint health and digestive health.

  Be the first to like this.
 


 

11149 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AAC 1.0350.00 
 TPO 0.090.00 
 NCMLOD 2.020.00 
 NCMLOF 3.130.00 
 AAJ 0.0060.00 
 WPLKOV 4.350.00 
 AAR 0.0660.00 
 VMX 0.3150.00 
 AAU 0.0090.00 
 MPL 3.410.00 
Partners & Brokers